|
127 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3245 News |
|
| «12...4041424344454647484950...6566» |
- ||||| Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
New P2 trial: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis (clinicaltrials.gov) - Jan 16, 2014
P2, N=277, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
- Trial completion, Adherence: TBsurvey: Access to Care and Adherence Tuberculosis (TB) Survey (clinicaltrials.gov) - Jan 16, 2014
P=N/A, N=137, Completed, Sponsor: Azienda Ospedaliera San Gerardo di Monza
Recruiting --> Completed
- AZD5847 / AstraZeneca
Trial completion, P2a data: Phase 2a EBA Trial of AZD5847 (clinicaltrials.gov) - Jan 15, 2014
P2, N=75, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- ceftriaxone / Generic mfg., gentamicin sulfate / Generic mfg.
Enrollment closed: Infaseme: Infant Severe Sepsis and Bacterial Meningitis in Malawi (clinicaltrials.gov) - Jan 14, 2014
P4, N=238, Active, not recruiting, Sponsor: University of Malawi College of Medicine
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed: Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda (clinicaltrials.gov) - Jan 13, 2014
P=N/A, N=250, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | New P4 trial: INFECIR2: The INFECIR-2 Albumin Prevention Study (clinicaltrials.gov) - Jan 9, 2014
P4, N=512, Not yet recruiting, Sponsor: EASL - CLIF Consortium
- ||| New P1 trial: Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults (clinicaltrials.gov) - Jan 9, 2014
P1, N=52, Recruiting, Sponsor: Novartis
- | flucloxacillin sodium / Generic mfg.
New P4 trial: DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) - Jan 8, 2014
P4, N=396, Not yet recruiting, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- ||| Altabax (retapamulin) / GSK, Almirall
Enrollment open: ALTARGOPMS: ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) (clinicaltrials.gov) - Jan 8, 2014
P=N/A, N=3000, Recruiting, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- ||||||| Infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) / GSK, Rotarix (rotavirus vaccine) / GSK, Engerix-B (hepatitis B vaccine recombinant) / GSK
Trial completion: Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants (clinicaltrials.gov) - Jan 8, 2014
P3, N=4003, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
Clinical: EVOTAR: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients. (clinicaltrials.gov) - Jan 7, 2014
P=N/A, N=300, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Enrollment closed: PCV13-Bobo: Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso (clinicaltrials.gov) - Jan 6, 2014
P4, N=765, Active, not recruiting, Sponsor: Agence de Médecine Préventive, France
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- Trial completion: ETAT: Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy (clinicaltrials.gov) - Jan 5, 2014
P=N/A, N=430, Completed, Sponsor: Assistance Publique - H
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: The Impact of Vitamin D on Tuberculosis Among Koreans (clinicaltrials.gov) - Jan 2, 2014
P=N/A, N=203, Completed, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed N=298 --> 203
- Enrollment change: Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients (clinicaltrials.gov) - Jan 2, 2014
P=N/A, N=49, Completed, Sponsor: Seoul National University Hospital
N=298 --> 203 N=25 --> 49
- Trial completion: The Impact of Vitamin D on Tuberculosis Among Koreans (clinicaltrials.gov) - Jan 2, 2014
P=N/A, N=203, Completed, Sponsor: Seoul National University Hospital
N=25 --> 49 Recruiting --> Completed
- Trial completion: Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients (clinicaltrials.gov) - Jan 2, 2014
P=N/A, N=49, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed Recruiting --> Completed
- || Shanchol (oral cholera vaccine) / Sanofi
New P3 trial: SCVB: Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh (clinicaltrials.gov) - Jan 2, 2014
P3, N=204438, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- | Mycidac-C (mycobacterium indicus pranii heat-killed) / Cadila
Trial completion, Immunomodulating: Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients (clinicaltrials.gov) - Jan 2, 2014
P3, N=1020, Completed, Sponsor: Ministry of Science and Technology, India
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed, IO biomarker: Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (clinicaltrials.gov) - Jan 1, 2014
P1, N=48, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe (clinicaltrials.gov) - Dec 29, 2013
P=N/A, N=96, Completed, Sponsor: Program for Appropriate Technology in Health
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Biomarker, Trial completion: CURIOSITY: Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections (clinicaltrials.gov) - Dec 28, 2013
P=N/A, N=1001, Completed, Sponsor: MeMed Diagnostics Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs (clinicaltrials.gov) - Dec 22, 2013
P=N/A, N=80, Completed, Sponsor: Ramathibodi Hospital
Active, not recruiting --> Completed Enrolling by invitation --> Completed
- Betadine (povidone iodine) / Egis
Trial completion: PJB 1: PVP Iodine Effect on Post Debridement Bacteraemia (clinicaltrials.gov) - Dec 19, 2013
P4, N=20, Completed, Sponsor: University of Zurich
Enrolling by invitation --> Completed Not yet recruiting --> Completed
- | New P1 trial: A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. (clinicaltrials.gov) - Dec 19, 2013
P1, N=50, Recruiting, Sponsor: Novartis
- ||| Abthrax (raxibacumab) / Emergent Biosolutions
New P2/3 trial: An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection (clinicaltrials.gov) - Dec 18, 2013
P2/3, N=20, Completed, Sponsor: Human Genome Sciences Inc.
- |||||||||| Baxdela (delafloxacin) / Menarini, Melinta Therap
New P3 trial: Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea (clinicaltrials.gov) - Dec 17, 2013
P3, N=757, Recruiting, Sponsor: Melinta Therapeutics, Inc.
- ||| Enrollment open: Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT) (clinicaltrials.gov) - Dec 17, 2013
P=N/A, N=700, Recruiting, Sponsor: T2 Biosystems
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Enrollment change: Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine (clinicaltrials.gov) - Dec 16, 2013
P3, N=389, Completed, Sponsor: Novartis Vaccines
Not yet recruiting --> Recruiting N=866 --> 389
- ||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
Enrollment closed: Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) (clinicaltrials.gov) - Dec 15, 2013
P4, N=190, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
N=866 --> 389 Recruiting --> Active, not recruiting
- | MTBVAC / Zendal Group
New P1 trial: Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (clinicaltrials.gov) - Dec 15, 2013
P1, N=36, Active, not recruiting, Sponsor: Biofabri, S.L
- |||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Trial completion: CAPITA: Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults (clinicaltrials.gov) - Dec 15, 2013
P4, N=84496, Completed, Sponsor: Pfizer
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||| Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
Enrollment open: Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections (clinicaltrials.gov) - Dec 14, 2013
P3, N=150, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis (clinicaltrials.gov) - Dec 13, 2013
P=N/A, N=160, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||| Deltyba (delamanid) / Otsuka
Enrollment change: Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis (clinicaltrials.gov) - Dec 12, 2013
P3, N=511, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting --> Completed N=390 --> 511
- ||||| Deltyba (delamanid) / Otsuka
Enrollment closed: Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis (clinicaltrials.gov) - Dec 12, 2013
P3, N=511, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
N=390 --> 511 Recruiting --> Active, not recruiting
- PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
New P3 trial, Pneumococcal vaccines: PCV13HIV2011: Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults (clinicaltrials.gov) - Dec 12, 2013
P3, N=50, Completed, Sponsor: University of Siena
- Trial completion: The Epidemiology of TST Change in Korea (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=5552, Completed, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- azithromycin / Generic mfg.
Enrollment change: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed N=2640 --> 1373
- |||| amikacin/fosfomycin inhalation (AFIS) / Savara
Enrollment open, Gram negative: Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia (clinicaltrials.gov) - Dec 10, 2013
P2, N=150, Recruiting, Sponsor: Cardeas Pharma
N=2640 --> 1373 Not yet recruiting --> Recruiting
- azithromycin / Generic mfg.
Trial completion: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
Not yet recruiting --> Recruiting Recruiting --> Completed
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial initiation date: Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults (clinicaltrials.gov) - Dec 9, 2013
P4, N=360, Not yet recruiting, Sponsor: University of Witwatersrand, South Africa
Recruiting --> Completed Initiation date: Mar 2013 --> Mar 2014
- Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Enrollment open: Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents (clinicaltrials.gov) - Dec 9, 2013
P1, N=8, Recruiting, Sponsor: Cempra Pharmaceuticals
Initiation date: Mar 2013 --> Mar 2014 Not yet recruiting --> Recruiting
- | vancomycin / Generic mfg., ceftriaxone / Generic mfg., ceftaroline fosamil / Generic mfg.
Enrollment change: Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus (clinicaltrials.gov) - Dec 8, 2013
P4, N=49, Completed, Sponsor: Cerexa, Inc.
Not yet recruiting --> Recruiting N=225 --> 49
- Enrollment open: Peristeen Bowel Irrigation System in Cauda Equina (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=10, Recruiting, Sponsor: University of Manitoba
N=225 --> 49 Not yet recruiting --> Recruiting
- | Trial completion: Dose Escalation Study of Valortim (clinicaltrials.gov) - Dec 5, 2013
P1, N=28, Completed, Sponsor: PharmAthene, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||| Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi, Nimenrix (MenACWY-TT) / Pfizer
Trial completion: The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults (clinicaltrials.gov) - Dec 4, 2013
P2, N=818, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| moxifloxacin ophthalmic / Generic mfg., ofloxacin ophthalmic / Generic mfg.
Enrollment change: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients (clinicaltrials.gov) - Dec 3, 2013
P3, N=1042, Recruiting, Sponsor: Alcon Research
Active, not recruiting --> Completed N=434 --> 1042
- Enrollment change: the DASH Study: Vitamin D and Sexual Health (clinicaltrials.gov) - Dec 2, 2013
P=N/A, N=118, Completed, Sponsor: Ohio State University
N=434 --> 1042 N=150 --> 118
- Enrollment change: Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis (clinicaltrials.gov) - Dec 2, 2013
P=N/A, N=234, Completed, Sponsor: National Taiwan University Hospital
N=150 --> 118 N=150 --> 234